Skip to main content

EMT2 News

EMT2 – A double-blind randomised controlled trial of the omega-3 fatty acid EPA in patients undergoing liver surgery for colorectal cancer liver metastasis

NEWS

Posts not found

Posts not found

Posts not found

Posts not found

Posts not found

Posts not found